中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
21期
124-125
,共2页
缺铁性贫血%铁剂%促红细胞生成素
缺鐵性貧血%鐵劑%促紅細胞生成素
결철성빈혈%철제%촉홍세포생성소
Iron-deficiency anemia%Iron%Erythropoietin
目的：探讨铁剂联合促红细胞生成素治疗缺铁性贫血的临床疗效，为临床推广做出指导。方法选择该院自2010年1月-2013年1月收治的86例缺铁性贫血的患儿为研究对象，将其完全随机分为两组，对照组患者给予蛋白琥珀酸铁口服液治疗，观察组患者则在对照组的基础上给予重组人红细胞生成素治疗，对比观察两组患儿的临床治疗效果。结果观察组治疗后血红蛋白（97.69±18.46） g/L、血清铁蛋白（17.59±3.98） g/L、以及血细胞比积（37.59±6.68）%等各项指标均优于对照组治疗后血红蛋白（81.32±16.11） g/L、血清铁蛋白（14.16±3.21） g/L、以及血细胞比积（28.35±6.03）%，差异有统计学意义（P<0.05）。结论铁剂联合促红细胞生成素治疗缺铁性贫血的临床疗效显著，能够改善患儿的缺血症状，值得临床广泛推广。
目的：探討鐵劑聯閤促紅細胞生成素治療缺鐵性貧血的臨床療效，為臨床推廣做齣指導。方法選擇該院自2010年1月-2013年1月收治的86例缺鐵性貧血的患兒為研究對象，將其完全隨機分為兩組，對照組患者給予蛋白琥珀痠鐵口服液治療，觀察組患者則在對照組的基礎上給予重組人紅細胞生成素治療，對比觀察兩組患兒的臨床治療效果。結果觀察組治療後血紅蛋白（97.69±18.46） g/L、血清鐵蛋白（17.59±3.98） g/L、以及血細胞比積（37.59±6.68）%等各項指標均優于對照組治療後血紅蛋白（81.32±16.11） g/L、血清鐵蛋白（14.16±3.21） g/L、以及血細胞比積（28.35±6.03）%，差異有統計學意義（P<0.05）。結論鐵劑聯閤促紅細胞生成素治療缺鐵性貧血的臨床療效顯著，能夠改善患兒的缺血癥狀，值得臨床廣汎推廣。
목적：탐토철제연합촉홍세포생성소치료결철성빈혈적림상료효，위림상추엄주출지도。방법선택해원자2010년1월-2013년1월수치적86례결철성빈혈적환인위연구대상，장기완전수궤분위량조，대조조환자급여단백호박산철구복액치료，관찰조환자칙재대조조적기출상급여중조인홍세포생성소치료，대비관찰량조환인적림상치료효과。결과관찰조치료후혈홍단백（97.69±18.46） g/L、혈청철단백（17.59±3.98） g/L、이급혈세포비적（37.59±6.68）%등각항지표균우우대조조치료후혈홍단백（81.32±16.11） g/L、혈청철단백（14.16±3.21） g/L、이급혈세포비적（28.35±6.03）%，차이유통계학의의（P<0.05）。결론철제연합촉홍세포생성소치료결철성빈혈적림상료효현저，능구개선환인적결혈증상，치득림상엄범추엄。
Objective To investigate the clinical effect of iron combined with erythropoietin in the treatment of iron-deficiency anemia so as to provide guidance for the clinical promotion. Methods 86 cases of children with iron-deficiency anemia admitted in our hospital from January 2010 to January 2013 were selected as the object of study, and they were randomly divided into two groups. Patients in the control group were treated with iron proteinsuccinylate oral solution, and patients in the observation group were given recombinant human erythropoietin treatment on the basis of the treatment of the control group. The clinical treatment effect of these two groups of children was observed and compared. Results After the treatment, the hemoglobin of the observation group was (97.69 ±18.46 )g/L, serum ferritin was (17.59 ±3.98) g/L, haematocrit was (37.59 ±6.68)%, the hemoglobin of the control group was (81.32±16.11 )g/L, serum ferritin was (14.16±3.21) g/L, haematocrit was (28.35±6.03) %, the indicators of the observa-tion group were better than those of the control group after treatment, the differences between the two groups were statistically sig-nificant (P<0.05). Conclusion The therapeutic effect of iron combined with erythropoietin for the treatment of iron-deficiency ane-mia is significant, which can improve the ischemic symptoms of the children, and is worthy of extensive clinical application.
